ArticleFrontiers in medicine2025
Hepatic steatosis mediates the relationship between cholecystectomy and BMI increase: a population-based study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cholecystectomy has been linked with adverse metabolic outcomes, but its specific association with body mass index (BMI) and the underlying mechanisms remain insufficiently understood. This study aimed to assess the impact of cholecystectomy on BMI and examine the mediating role of hepatic steatosis. Methods: A total of 7,452 adults were included in this cross-sectional analysis. Baseline demographic, clinical, and laboratory data were compared between participants with and without cholecystectomy. Multivariable linear regression was used to evaluate the relationship between cholecystectomy and BMI, with progressive adjustment for demographic, clinical, and metabolic-inflammatory confounders. Subgroup and stratified analyses, propensity score modeling, and causal mediation analysis were conducted to validate findings and elucidate potential mechanisms. Results: Participants with cholecystectomy were older (mean age 61.0 vs. 49.5 years), more likely to be female, and exhibited higher BMI (mean 31.8 ± 8.1 cholecystectomy group vs. 29.6 ± 7.3 non-cholecystectomy, Conclusions: Cholecystectomy is independently associated with increased BMI, particularly among younger adults, and this relationship is partially mediated by hepatic steatosis. These findings highlight the need for long-term metabolic monitoring and targeted interventions in patients undergoing cholecystectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.